Invention paves the way to better ovarian cancer diagnosis (w/ Video)

July 31, 2015

Overseen by her thesis supervisor and in collaboration with B.C. Cancer Agency scientists, a Simon Fraser University doctoral student is developing a faster, more reliable way to diagnose ovarian cancer.

Computing science student Aïcha BenTaieb is designing a computer-aided diagnostic system at SFU's Medical Image Analysis Lab that will more accurately and more quickly identify ovarian 's many subtypes than the current technique.

Currently, before treatment can begin, pathologists use a microscope to identify tissue samples from cancerous ovarian tumours. According to OVCARE, a B.C.-based ovarian cancer research team, every three-and-a-half-hours in Canada a woman is diagnosed with —one of the most fatal and least understood cancers. Time is of the essence.

With research help from SFU computing science professor Ghassan Hamarneh and B.C. Cancer Agency pathologists Drs. David Huntsman and Hector Li Chang, BenTaieb's automated system will speed up decision-making on appropriate chemo- or radiation therapies.

"Traditional classification can be easily impaired by technical factors such as lighting and the pathologist's experience," explains BenTaieb. "Despite having guidelines for diagnosis, each pathologist has his or her own understanding of the disease, and the act of visually classifying something remains subjective. Classification can also be costly, as non-expert pathologists require long hours of training and additional testing might be needed."

BenTaieb's computer prototype is programmed to classify the appropriate cancer subtype using expert-annotated tissue-sample images. They have an agreed-upon subtype verified through biological testing.

The system's built-in artificial intelligence is then able to interpret tissue samples and identify the appropriate cancer subtype by comparing the sample's visual appearance to annotated images.

So far, the results have been promising. The system is already correctly classifying the subtypes in more than 92 per cent of cases.

BenTaieb will present her research paper on this development at the 18th International Conference on Medical Imaging Computing and Computer Assisted Intervention (MICCAI) in Munich, Germany, Oct. 5 to 9. Her paper is called "Automatic Diagnosis of Ovarian Carcinomas via Sparse Multi-resolution Tissue Representation".

Explore further: New research from Lawson uncovers important molecule in ovarian cancer

Related Stories

New research from Lawson uncovers important molecule in ovarian cancer

July 22, 2015
Scientists at Lawson Health Research Institute have uncovered an important new target for ovarian cancer therapy. Contrary to current research this new study found that LKB1, a molecule that regulates the metabolism of many ...

Survival improving for women with ovarian cancer

May 12, 2015
(HealthDay)—Women diagnosed with ovarian cancer are now much more likely to survive the disease than they were several decades ago, according to research published online May 6 in Obstetrics & Gynecology.

Mesothelial cells promote ovarian cancer metastasis

September 9, 2014
Less than half of the women diagnosed with ovarian cancer will survive beyond 5 years. Ovarian cancer readily spreads to abdominal organs, which are covered by a layer of cells called the mesothelium. Ovarian cancer cells ...

Ovarian cancer: Genetic testing should be accessible to all women with the disease

April 15, 2015
The genes BRCA1 and BRCA2 play a significant role in hereditary breast and ovarian cancers. Recent media attention has focused on American actress Angelina Jolie's decision to have her ovaries and fallopian tubes surgically ...

'Spectral histopathology' facilitates prognosis regarding tumour aggressiveness

April 20, 2015
A new diagnostic method, namely spectral histopathology, facilitates marker-free detection of individual subtypes of lung cancers. It was developed by researchers at the PURE consortium at Ruhr-Universität Bochum (RUB). ...

Spotting ovarian cancer, before it's too late

December 19, 2012
(Medical Xpress)—At just 28 percent, the five-year survival rate for women diagnosed with ovarian cancer is much lower than in other cancer cases. And, the disease can easily go unnoticed, making it difficult to find effective ...

Recommended for you

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.